Research Article |
Corresponding author: Krassimira Zaykova ( krassimira2georgieva@gmail.com ) Academic editor: Ilko Getov
© 2025 Krassimira Zaykova, Silviya Nikolova, Rouzha Pancheva, Asena Serbezova, Ralitsa Zlatanova-Velikova.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Zaykova K, Nikolova S, Pancheva R, Serbezova A, Zlatanova-Velikova R (2025) Impact of demographic and professional factors on antibiotic prescription patterns in the post-COVID-19 era. Pharmacia 72: 1-9. https://doi.org/10.3897/pharmacia.72.e139140
|
This study examines self-reported changes in antibiotic prescribing practices among 222 physicians post-COVID-19, focusing on factors influencing these changes. The sample had a mean age of 47.7 years (SD = 11.1), with 62.2% female participants. Statistical analyses included Mann-Whitney U tests and logistic regression to identify predictors of prescribing changes.
Physicians reporting changes were more likely to prescribe antibiotics due to patient demand (U = 2725, p < 0.001), time constraints (U = 3158, p < 0.01), concerns about complications (U = 2803, p < 0.01), and peer behavior (U = 3190, p < 0.01). Logistic regression revealed that age predicted changes in prescribing behavior (OR = 1.0831, p = 0.029), while professional experience (OR = 0.9274, p = 0.044) and additional specializations (OR = 0.3835, p = 0.023) were inversely related. Residence in villages showed a trend toward increased prescribing (OR = 7.8055, p = 0.097).
These findings underscore the influence of demographic, professional, and geographic factors on antibiotic prescribing practices. Future research should investigate the long-term effects on antibiotic resistance and evaluate targeted interventions to address the identified drivers of prescribing behavior.
antimicrobial resistance, evidence-based medicine, physician behavior
Antibiotic resistance has been a long-standing global health issue, largely driven by the overuse and inappropriate prescribing of antibiotics (
Physicians’ prescribing habits are shaped by their medical training, awareness of antimicrobial resistance, patient expectations, and diagnostic uncertainties (
Adherence to clinical guidelines typically improves prescribing practices, but not all physicians consistently follow them (
Physician experience and specialty significantly affect antibiotic prescribing. More experienced physicians may be better at avoiding unnecessary prescriptions, particularly for viral infections (
The COVID-19 pandemic has dramatically impacted healthcare systems and altered antibiotic prescribing practices. Increased demand for healthcare services, along with managing COVID-19 cases and potential co-infections, has led to a surge in antibiotic use (
Social media has also played a role in shaping medical practices during the pandemic, as misinformation and online discussions may influence physicians’ prescribing decisions (
This study aims to investigate how the COVID-19 pandemic has altered antibiotic prescribing patterns among physicians in Bulgaria, with a particular focus on the demographic and professional factors influencing these changes.
The study employed a cross-sectional, multicenter survey design, conducted between January and March 2023. It targeted general practitioners and specialist physicians from both inpatient and outpatient settings across Bulgaria. Participants were invited to complete an anonymous online questionnaire hosted on Google Forms. The purpose of the survey was to explore changes in antibiotic prescription patterns in the post-COVID-19 period. This design allows for a snapshot of current prescribing behaviors and the factors influencing these practices.
The survey population consisted of individuals representing a range of medical specialties, including but not limited to general practitioners, pediatricians, otorhinolaryngologists, internal medicine specialists, microbiologists, and surgeons. Eligibility criteria encompassed both specialists holding postgraduate degrees or diplomas, as well as non-specialists with a master‘s degree in medicine. Physicians from different regions across Bulgaria were invited through a nationwide distribution effort facilitated by the Bulgarian Medical Association. Participation was voluntary, and all participants provided informed consent before completing the survey.
The self-administered questionnaire was designed to capture comprehensive data across five sections:
The questionnaire was not formally validated prior to the study; however, its clarity was tested with a small group of 4 medical professionals. This group provided feedback on the wording and structure of the questions, helping to refine the content and ensure its precision. Although no formal pilot testing was performed, this review process was crucial for confirming the relevance of the questions and ensuring they effectively captured the data needed for the study. Additionally, the design of the survey was informed by existing literature and expert input, contributing to its reliability.
The study included 222 physicians who participated in the online survey. While the sample provided valuable insights into antibiotic prescribing practices, it is important to acknowledge that it is not representative of the broader physician population in Bulgaria. The survey targeted both inpatient and outpatient physicians, ensuring a diverse range of clinical experiences. However, the online format and voluntary nature of participation may have introduced selection biases, limiting the generalizability of the findings. As a result, the sample reflects the perspectives of those who opted to participate but may not fully capture the prescribing behaviors across all healthcare providers in the country.
Descriptive statistics, such as means, standard deviations, and percentages, were used to summarize demographic characteristics and prescription behaviors. Mann-Whitney U tests were conducted to compare physicians who reported changes in antibiotic prescription post-COVID-19 with those who did not, given the ordinal nature of the data and potential non-normal distributions. Significance levels were set at p ≤ 0.05, p ≤ 0.001, and p ≤ 0.0001 to discern statistical significance. Additionally, logistic regression analysis was performed to explore the association between demographic/professional factors and changes in antibiotic prescription practices. “Changes in antibiotic prescription practices” referred to the self-reported practices of antibiotic prescription, particularly in response to evolving external factors such as the COVID-19 pandemic. This was measured using a Likert scale, where participants rated the likelihood of specific prescribing behaviors from 0 (“I never do it”) to 4 (“I always do it”). This scale allowed for an assessment of how frequently certain practices were adopted or modified, providing insight into shifts in antibiotic prescribing patterns over time. The analyses were carried out using the Jamovi v 2.3 software for Windows.
The sample comprised 222 participants with an average age of 47.7 ± 11.1 years, indicating variability within the cohort. Gender distribution showed a predominance of females (62.2%) compared to males (37.8%). Participants reported an average of 18.7 ± 10.7 years of professional experience, reflecting a diverse range of experience levels. The majority of participants worked in regional cities (87.4%), while smaller proportions worked in small cities (10.8%) or villages (1.8%). Ethnicity was predominantly Bulgarian (95.4%), with a minority identifying as other ethnicities (4.6%). In terms of practice settings, approximately one-third were general practitioners (29.7%), while half worked in outpatient units (50.5%), and the remaining portion practiced in hospital units (19.8%) (Table
N = 222 | |
Age | 47.7 ± 11.1 |
Gender | |
Male | 37.8% (n = 84) |
Female | 62.2% (n = 138) |
Years of Experience | 18.7 ± 10.7 |
Place of work | |
Regional city | 87.4%(n = 1944) |
Small city | 10.8% (n = 24) |
Village | 1.8% (n = 4) |
Ethnicity | |
Bulgarian | 95.4% (n = 209) |
Other | 4.6% (n = 10) |
Practice | |
General Practitioners | 29.7% (n = 66) |
Working in Outpatient Units | 50.5% (n = 112) |
Working in Hospital Units | 19.8% (n = 44) |
Table
Reasons for antibiotic prescription | Group | N | Mean | SD | Mann-Whitney U |
---|---|---|---|---|---|
After the antibiogram is made. | No change | 157 | 2.68 | 0.893 | 2551*** |
Change | 47 | 2.19 | 0.770 | ||
After blood test showing bacterial infection. | No change | 157 | 2.93 | 0.907 | 2857** |
Change | 47 | 2.64 | 0.705 | ||
When I judge clinically that it is a bacterial infection. | No change | 157 | 2.83 | 0.861 | 3606 |
Change | 47 | 2.85 | 0.807 | ||
Due to the patient’s expressed desire for antibiotic treatment. | No change | 157 | 1.15 | 0.378 | 2725*** |
Change | 47 | 1.45 | 0.583 | ||
Due to incentives from pharmaceutical companies. | No change | 157 | 1.01 | 0.113 | 3499* |
Change | 47 | 1.11 | 0.429 | ||
Due to lack of time. | No change | 157 | 1.08 | 0.339 | 3158** |
Change | 47 | 1.26 | 0.530 | ||
When I know the patient well, no further tests. | No change | 157 | 1.60 | 0.669 | 2854** |
Change | 47 | 1.91 | 0.775 | ||
I prescribe when I worry about possible complications regardless of the results from the clinical analysis. | No change | 157 | 1.92 | 0.816 | 2803** |
Change | 47 | 2.26 | 0.846 | ||
I prescribe more often before holidays/weekends. | No change | 157 | 1.13 | 0.419 | 2870*** |
Change | 47 | 1.47 | 0.804 | ||
I prescribe more often at the end of the workday. | No change | 157 | 1.07 | 0.280 | 3363 |
Change | 47 | 1.26 | 0.706 | ||
I prescribe more often at the beginning of the workday. | No change | 157 | 1.11 | 0.417 | 3317* |
Change | 47 | 1.36 | 0.845 | ||
I prescribe because I worry that another colleague will do it after me. | No change | 157 | 1.08 | 0.350 | 3190** |
Change | 47 | 1.30 | 0.720 |
Furthermore, physicians who changed their practices were more inclined to prescribe antibiotics due to external factors, such as incentives from pharmaceutical companies (U = 3499, p < 0.05), time constraints (U = 3158, p < 0.01), and concerns about potential complications (U = 2803, p < 0.01). Differences were also noted in prescription behaviors related to specific clinical circumstances, including patient preferences (U = 2725, p < 0.001), professional workload (U = 2870, p < 0.0001), and temporal factors, such as prescribing before holidays or weekends (U = 2870, p < 0.0001).
Additionally, physicians who reported changes in their practices were more likely to prescribe antibiotics due to perceived time constraints (M = 1.26 ± 0.530) compared to those who did not (M = 1.08 ± 0.339), U = 3158, p < 0.01. They also showed a higher tendency to prescribe antibiotics when they had established relationships with patients and opted not to conduct further tests (M = 1.91 ± 0.775) compared to their counterparts (M = 1.60 ± 0.669), U = 2854, p < 0.01. Moreover, concerns about potential complications led physicians who changed their practices to prescribe antibiotics more frequently (M = 2.26 ± 0.846) than those who did not (M = 1.92 ± 0.816), U = 2803, p < 0.01. Lastly, apprehensions regarding the prescribing behavior of colleagues also influenced prescription decisions, as physicians who changed their practices were more likely to prescribe antibiotics for this reason (M = 1.30 ± 0.720) compared to those who did not (M = 1.08 ± 0.350), U = 3190, p < 0.01.
Logistic regression was used to test what factors could possibly contribute to changes in antibiotic prescription after COVID-19. The model fit measures indicate a good fit: deviance of 194, AIC of 214, explaining around 10.2% of the variance (R²), and statistical significance in explaining the outcome variable (McF χ² = 22.1, df = 9, p = 0.009).
Age emerged as a significant factor (OR = 1.0831, p = 0.029), with each additional year associated with an 8.31% increase in the odds of reporting a change in prescription behavior. Conversely, years of professional experience were inversely related to changes in prescription behavior (OR = 0.9274, p = 0.044), with each additional year decreasing the odds by approximately 7.26%. Holding additional specializations significantly decreased the likelihood of reporting changes (OR = 0.3835, p = 0.023), with individuals with additional specializations being approximately 61.5% less likely to report changes. Gender did not have a significant impact on changes in prescription behavior (OR = 0.8552, p = 0.683). Similarly, practitioners in outpatient practice (OR = 0.4660, p = 0.085) and those in hospital practice (OR = 0.5365, p = 0.223) did not demonstrate significant effects either. Residence in villages demonstrated a trend toward significance in its association with changes in prescription behavior (OR = 7.8055, p = 0.097). Additionally, residing in small towns did not have a significant effect on changes in prescription behavior (OR = 0.3778, p = 0.136), suggesting that small-town residency does not substantially influence prescribing practices.
Age played a significant role in changes to prescription behavior (OR = 1.0831, p = 0.029), with older physicians more likely to report changes. In contrast, more years of professional experience were linked to a lower likelihood of reporting changes (OR = 0.9274, p = 0.044). Physicians with additional specializations were also less likely to report changes (OR = 0.3835, p = 0.023). While living in a village showed a trend toward significance (OR = 7.8055, p = 0.097), residing in a small town had no significant impact (OR = 0.3778, p = 0.136) (Table
Predictor | Estimate | SE | Z | P | Odds ratio | 95% Confidence Interval | |
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Intercept | -2.6891 | 1.2741 | -2.111 | 0.035 | 0.0679 | 0.00559 | 0.825 |
Gender | |||||||
Men-women | -0.1564 | 0.3834 | -0.408 | 0.683 | 0.8552 | 0.40336 | 1.813 |
Place of residence | |||||||
Small city – Regional city | -0.9734 | 0.6536 | -1.489 | 0.136 | 0.3778 | 0.10494 | 1.360 |
Village– regional city | 2.0548 | 1.2397 | 1.658 | 0.097 | 7.8055 | 0.68733 | 88.642 |
Age | 0.0798 | 0.0366 | 2.181 | 0.029 | 1.0831 | 1.00814 | 1.164 |
Years of experience | -0.0754 | 0.0375 | -2.010 | 0.044 | 0.9274 | 0.86161 | 0.998 |
Practice | |||||||
Working in Outpatient Units – General Practitioner | -0.7635 | 0.4428 | -1.724 | 0.085 | 0.4660 | 0.19565 | 1.110 |
Working in Hospital Units – General Practitioner | -0.6227 | 0.5105 | -1.220 | 0.223 | 0.5365 | 0.19726 | 1.459 |
Additional Specialization | |||||||
yes – no | -0.9585 | 0.4203 | -2.280 | 0.023 | 0.3835 | 0.16824 | 0.874 |
Alternative Medicine | |||||||
yes – no | -0.0580 | 0.3794 | -0.153 | 0.879 | 0.9437 | 0.44862 | 1.985 |
This study offers insights into how demographic and professional factors have influenced changes in antibiotic prescription patterns in the post-COVID-19 era. Our findings suggest that older age and fewer years of professional experience are linked to a greater likelihood of changes in antibiotic prescription behavior following the pandemic. This trend may arise from older clinicians demonstrating enhanced adaptability in the evolving treatment landscape, while less experienced practitioners may be more willing to modify their practices. Interestingly, physicians with additional specializations appear to experience a protective effect, as they were less likely to report changes in their antibiotic prescribing habits, possibly reflecting greater clinical knowledge and confidence in their decision-making.
Conversely, the observed inverse relationship between years of professional experience and changes in prescribing patterns could be attributed to entrenched prescribing habits and potential resistance to adopting new practices. Supporting this, a Canadian study of family physicians analyzed 5.6 million antibiotic prescriptions from 10,616 doctors and found that age and career stage were significant predictors of antibiotic duration; late-career and older physicians tended to prescribe longer courses compared to their early-career counterparts (
Our study found significant differences in antibiotic prescribing practices between physicians who reported changes after COVID-19 and those who did not. The higher reluctance to prescribe antibiotics when an antibiogram was available among physicians who changed their prescribing habits suggests a more cautious and evidence-based approach to antibiotic selection. In contrast, physicians who changed their habits displayed an increased tendency to prescribe antibiotics in response to patient preferences or demands, as well as under the influence of external factors such as pharmaceutical incentives and time constraints. The observed differences in prescription behaviors, particularly related to clinical decision-making factors such as antibiogram availability, patient preferences, and concerns about potential complications, highlight the complex interplay between individual, professional, and contextual factors in shaping antibiotic usage patterns. Antibiograms are valuable tools for guiding empiric antibiotic prescribing, but their utilization by physicians remains suboptimal as there is often a mismatch between antibiogram recommendations and actual prescribing practices (
On the other hand, factors like gender, practice setting, and use of alternative medicine did not significantly influence changes in prescription patterns of medical doctors in Bulgaria. This is contrary to other studies in which it has been observed that factors such as physicians’ gender, practice type, and location also affect prescribing behavior (
Limitations of this study include the self-reported nature of the data, which may be subject to recall bias or social desirability bias, and the cross-sectional design, which precludes inferences about causal relationships. Ultimately, understanding the impact of these factors can inform the development of targeted strategies to promote responsible antibiotic use, reduce the rise of antimicrobial resistance, and ensure optimal patient outcomes in the evolving post-pandemic landscape. By addressing the specific demographic and professional influences on antibiotic prescribing, healthcare systems can implement more effective and personalized interventions to foster responsible antibiotic use and safeguard public health in the years to come.
As we look to the future, it is vital to draw lessons from the COVID-19 pandemic to shape more effective strategies for the safe and appropriate use of medicines, particularly antibiotics. In the context of shifting antibiotic prescribing behaviors, our findings highlight the complex interplay of individual, professional, and contextual factors that lead to changes in antibiotic usage patterns. Addressing antibiotic overuse requires a holistic, multifaceted approach by healthcare systems and policymakers. Tailored interventions must be developed to address the nuanced demographic and clinical characteristics of prescribers, as well as the evolving needs of patients and healthcare systems. By embracing a broad and evidence-based approach, we can empower clinicians, engage patients, and strengthen antibiotic stewardship to combat the growing threat of antimicrobial resistance and preserve public health.
Conflict of interest
The authors have declared that no competing interests exist.
Ethical statements
The authors declared that no clinical trials were used in the present study.
The authors declared that no experiments on humans or human tissues were performed for the present study.
Informed consent from the humans, donors or donors’ representatives: Participation was voluntary, and all participants provided informed consent before completing the survey. The informed consent have been deposited in the database of Google Forms.
The authors declared that no experiments on animals were performed for the present study.
The authors declared that no commercially available immortalised human and animal cell lines were used in the present study.
Funding
No funding was reported.
Author contributions
K. Zaykova conceived and designed the study, contributed to data analysis, and led the writing of the manuscript. S. P. Nikolova provided significant contributions to data analysis and statistical evaluation, and assisted in drafting the manuscript. R. Pancheva played a key role in the study’s methodology development, data collection, and interpretation of results. A. Serbezova assisted with data acquisition, contributed to the initial draft, and critically reviewed the manuscript for important intellectual content. R. Zlatanova-Velikova reviewed and revised the manuscript, provided insights on the discussion, and ensured the accuracy of the findings presented.
Author ORCIDs
Krassimira Zaykova https://orcid.org/0000-0002-8421-9493
Silviya Nikolova https://orcid.org/0000-0002-7325-0110
Rouzha Pancheva https://orcid.org/0000-0001-8286-3923
Asena Serbezova https://orcid.org/0000-0002-1949-1212
Ralitsa Zlatanova-Velikova https://orcid.org/0000-0003-0849-7341
Data availability
All data that support the findings reported in this study are available from the corresponding author upon reasonable request.
Annex A: Survey
Section 1: Informed Consent
Dear Sir/Madam,
You are invited to participate in a study on antibiotic use in Bulgaria. The increased use of antibiotics in Bulgaria is part of a broader trend observed in many developed and developing countries. However, it remains unclear how aware the public is of antibiotic treatments and what drives the overprescription of antibiotics among physicians in our country. Therefore, the main objective of this study is to determine the attitudes and practices related to antibiotic use among physicians in Bulgaria. The collected information will be used solely for research purposes.
As a participant in this study, you should be aware that: You will have the opportunity to complete the questionnaire only once. Participation in this study is voluntary and anonymous. You must be a physician to take part in the study. Completing the questionnaire takes approximately 5 minutes. There are no identified significant risks or inconveniences associated with your participation in the study.
Data Confidentiality: The collected information will remain confidential. You will not be required to provide your contact details as part of this study. Your identity as a participant in this study will remain confidential.
Contact Information: Should you need additional information, please contact me during working hours: Krasimira Zaykova, phone:…, or via email:… .
Consent:
1. If you agree to participate in the study and are a physician, please confirm your consent by selecting “Agree” and proceed to complete the questionnaire by marking your responses.
Section 2: Practice of Antibiotic Treatment
Very few (under 25%)/ I have almost no such patients | About 25% of my patients | About 50% of my patients | Over 75% of my patients | |
---|---|---|---|---|
Children (up to 18 years old) | ||||
Adults 18–60 years old | ||||
Adults over 60 years old |
1 – I don’t do it
2 – sometimes
3 – often
4 – always
1 – I don’t do it | 2 – sometimes | 3 – often | 4 – always | |
---|---|---|---|---|
After antibiogram is made. | ||||
After blood test showing bacterial infection. | ||||
When I judge clinically that it is a bacterial infection. | ||||
Due to the patient’s expressed desire for antibiotic treatment. | ||||
Due to incentives from pharmaceutical companies. | ||||
Due to lack of time. | ||||
When I know the patient well; no further tests. | ||||
I prescribe when I worry about possible complications regardless the results from the clinical analysis. | ||||
I prescribe more often before holidays/weekends. | ||||
I prescribe more often at the end of the work day. | ||||
I prescribe more often at the beginning of the work day. | ||||
I prescribe because I worry that another colleague will do it after me. |
1 – Yes, I prescribe more often;
2 – Yes, I prescribe less often;
3 – No change;
4 – Cannot determine.
1 – Yes, I prescribe based on the patient’s financial means;
2 – Yes, I always prescribe the cheaper option;
3 – Yes, I always prescribe the more expensive option;
4 – No, I do not consider the cost;
5 – Cannot determine.
Section 3: Your opinion on the use of antibiotics in the country as a whole
0 | 1 | 2 | 3 | 4 | |
Do you agree with the statement that there is a practice of overprescribing antibiotics in Bulgaria? | |||||
Do you believe that the use of antibiotics in animals is related to the development of antimicrobial resistance in the treatment of infections in humans? |
Scale: 1 – completely disagree 2 – somewhat disagree 3 – somewhat agree 4 – completely agree
1 | 2 | 3 | 4 | |
---|---|---|---|---|
Due to a strong desire for antibiotic treatment by the patient. | ||||
Due to incentives from pharmaceutical companies/representatives. | ||||
Due to lack of time to wait for blood test results and antibiogram. | ||||
Due to the stress and tension that fellow doctors experience while working. | ||||
Due to the claim that the doctor knows his patient well. | ||||
To reinsure himself the prescribing doctor. | ||||
Due to subsequent vacation or days off. | ||||
It is done more often at the end of the working day. | ||||
It is done more often at the beginning of the working day. | ||||
Due to concern that a subsequent doctor will do it. | ||||
Due to the accepted practice for treating this condition. |
Section 4: Demographic characteristics
A general practitioner
A general practitioner with an additional specialty
A specialist working in an outpatient unit
A specialist working in a hospital unit
…
Yes
No
…
…
Homeopathy
Herbal Therapy
Ayurveda
Chinese Medicine
Other
Male
Female
Other
…
Bulgarian ethnicity
Turkish ethnicity
Roma ethnicity
I do not wish to answer
Other
Regional city
Small town
Village